Background: Morbidity and mortality rates of Chronic obstructive pulmonary disease (COPD) are
INTRODUCTION
COPD has been defined as the presence of airway obstruction attributable to chronic bronchitis or emphysema (1) .
Morbidity and mortality rates of Chronic obstructive pulmonary disease (COPD) are continuously increasing throughout the world; it is a major cause of death and imposes as a great socioeconomic burden (2, 3) . COPD exacerbation is the main cause of ICU admissions and 4 th main reason of death (4) . The course of COPD is characterized with recurrent exacerbations and progressive deterioration of pulmonary functions. In addition to quality of life of patients being affected negatively, as the disease progresses need for ICU hospitalization increases and prognosis for this group of patients is believed to be poor (5) .
Studies report hospital mortality varies between 20% and 82% due to heterogeneous patient population and difference in severity of the disease (5) (6) (7) (8) . COPD patients who were admitted to ICU for acute hypercapnic respiratory failure have poor results, especially if intubation is needed, because they have had depleted body's reserve supplies. Type of ICU, co-morbid diseases, patient characteristics, age and severity of the disease determine high mortality rates of these patients (1, 9-13).
Defining predictive factors for morbidity and mortality in COPD patients has always been appealing for ICU specialists. Because determining high risk patient is essential for adjusting monitorization, approach and management of the disease and guidance for family members. Several factors for predicting mortality of COPD patients have been determined; these include need for mechanical ventilation, severity of underlying condition, renal failure, sepsis, presence of malignity, age, certain biochemical and physiological parameters, cardiac failure, arrhythmias, body mass index and APACHE II (Acute Physiological and Chronic
Health Evaluation) score (1, 8, 9, 13) .
In this study we aimed to examine effects of uric acid, Gamma-Glutamyl Transferase (GGT), Mean Platelet Volume (MPV) and Red cell Distribution Width (RDW) levels upon admission in addition to co-morbid diseases on mortality of COPD patients who were admitted to ICU.
MATERIAL AND METHOD

Setting
This study was conducted in Anesthesiology and Reanimation ICU department of a research and training hospital. Our hospital has 550 beds and includes all departments except obstetrics and gynecology. Semi-closed, 18 bed ICU is managed by anesthesiologists 24/7.
Anesthesiologists decide admittance and discharge of patients in ICU. All data in this study (physical examination findings, APACHE II, GCS and laboratory tests) are routinely done by the anesthesiologists during patient's admission to ICU. Nurse to patient ratio is 1/2 during the day shift and 1/3 during the night shift. There are no emergency, pulmonary and neurology ICU departments in our hospital.
After obtaining local Ethical Committee approval (Date 03.11.2015; Decree no:
37732058-6429) files of the COPD patients who were admitted to Anesthesiology and Reanimation ICU between January 2014 and December 2015 were examined retrospectively.
Among these 178 patients with COPD, 26 (%14.6) were admitted primarily to ICU because of COPD and acute exacerbation.
Patients
GCS (Glasgow Coma Scale), APACHE II score, presence of intubation, systolic-diastolic blood pressures (SBP-DBP), pulse rates, uric acid, GGT, blood glucose, CRP (C-Reactive Protein), urea, K (potassium), Na (sodium), total cholesterol, triglyceride, WBC, lymphocyte (%), neutrophile (%), MPV, RDW, PLT, ABG (Arterial blood gases); pH, PaCO2, PaO2, lactate, HCO3 and base excess upon admission for all of these 178 patients were recorded.
In addition history of DM (Diabetes Mellitus), HT (hypertension), CHF (congestive heart failure), ARF (acute renal failure), CRF (chronic renal failure), CVA (cerebrovascular accident), CAD (coronary artery disease) and sepsis were recorded. Echocardiography (ECHO) was performed and EF (ejection fraction, %) presence or absence of PHT (pulmonary hypertension), AF (atrial fibrillation) and pulmonary embolism were recorded.
Drug use that can affect uric acid levels such as insulin, statins, diuretics, ACE inhibitors and need for inotropic support upon admission were recorded.
Inclusion criteria: COPD patients who were hospitalized in ICU for at least one day and patients whose files were accessible were included in this study.
Exclusion criteria: Patients who were hospitalized for less than 24 hours and could not be diagnosed, patients whose laboratory results, ABG, GCS, APACHE II scores, medical histories and ECHO results could not be accessed were excluded from this study.
Biochemical tests
Blood Gases have been analyzed within ICU with ABL800 flexdevice. All samples were delivered to the laboratory within 30 minutes. Blood count was made by Abbott, Rubycelldyn, and CRP analysis made by Siemens BN II device and nephelometry. All biochemical parameters in the study were analyzed by Abbott Architect-C 16000 device and spectrophotometric method.
Statistics
Continuous variables are presented as mean±SD; discontinuous variables are presented as n (% There was no significant difference between deceased and surviving patients in terms of age and gender. Being intubated during admission was statistically more significant in deceased patients than surviving patients (p < 0.0001). Among deceased patients, the ratio of hospitalization due to acute COPD exacerbation was more than that of the ratio seen in the alive group (%18.3 vs %6.9; p = 0.045). Deceased patients had lower GCS and higher APACHE II scores than surviving patients (p < 0.0001 and p = 0.001 respectively). Durations of ICU hospitalization and mechanical ventilation were longer in deceased patients than surviving patients (p = 0.029 and p < 0.0001 respectively). SBP, DBP and MBP were significantly lower during admission in deceased patients than surviving patients (p=0.014, p<0.0001 and p=0.007 respectively). There was no statistically significant difference between groups in terms of pulse rate during admission (Table 1) .
Among the significant parameters in were independent variables to define mortality ( Table 2) .
Comparison of initial laboratory parameters
There was no significant difference between groups in terms of initial uric acid, GGT, WBC, RDW, CRP, glucose, triglyceride, total cholesterol, Na, K, urea, pH, PaO2, PaCO2 and HCO3 levels; whereas initial MPV, PLT, neutrophil, lymphocyte, creatinine and base excess levels were significantly different between deceased and surviving patients (Table 3) .
Among the significant parameters in table 3, PLT count, MPV, RDW, NLR, creatinine and BE were taken into logistic regression analysis using enter method which demonstrated that creatinine was the only independent laboratory parameterto define mortal patients (wald:
6.17, OR: 0.596 (95% CI: 0.397-0.897), p = 0.013) ( Table 4) .
Comparison of co-morbid diseases and drug use between two groups
There was significant difference between deceased and surviving patients in terms of CHF (p=0.004), post-CPR (0.010), pulmonary embolism (p=0.004), AF (p=0.041), initial inotropic support (p=0.050) and postoperative care (p=0.009); whereas other conditions did not have significant difference (Table 5) .
Multivariate logistic regression analysis was done including CHF, inotropic support in ICU, AF, Post-cpr and Post op. care using enter method. CHF (wald: 5.98, OR: 2.783 (95% CI: .004) were found to be independent parameters to define mortality among COPD patients in ICU (Table 6) .
DISCUSSION
The present study aimed to determine whether RDW, MPV, uric acid and co-morbid diseases were associated with mortality of all causes following ICU admission of patients with COPD.
We could not find any association with laboratory parameters independently except that of creatinine levels. But comorbidities, namely CHF and AF were strongly and independently correlated with mortality. Mortality rate in our study was 67.4%. This high rate may have some logical reasons; first our patients mainly consist of the elders, second 63.7% of our patients were already intubated during admission, third high frequency of co-morbid diseases, fourth %27 of our patients had accompanying pneumonia.
A study showed association between age and hospital mortality of COPD patients is affected by severity of the acute condition and other co-morbid diseases; and advanced age was a prognostic factor for hospital mortality (5) . There are other parameters besides age that determine prognosis of COPD patients who are admitted to ICU. It is shown in studies that in addition to prolonged oral corticosteroid use and high PaCO2 values (13); intubation and need for mechanical ventilation, inadequate compensation for respiratory acidosis, presence of mechanical ventilation complications, low GCS and high APACHE II score also are risk factors for mortality in COPD patients who were admitted to ICU (1, 8, 9, 11). Ucgun et al defined inadequate compensation for respiratory acidosis, low hemoglobin levels, low GCS and low DBP as independent risk factors for COPD patients who were admitted to ICU (1).
There are some other studies that define mechanical ventilation requirement for longer than 3 days, cardiac arrhythmias, low hemoglobin levels, coma, sepsis, iatrogenic complications, renal failure and accompanying pulmonary infections as important predictive factors for mortality of COPD and acute pulmonary failure patients who were admitted to ICU (1, 9, 11, 24-26). Our results were similar to these reports. there was no association between high levels of uric acid in first day of ICU hospitalization and mortality (17) . In a retrospective study that Seyhan et al conducted on 270 stable COPD patients, it was reported that elevated RDW levels were associated with increased mortality (31). Another study showed an independent association between high RDW levels and unfavorable results in ICU and emphasized it can be relatively predictive of clinical outcome (16) . On the other hand Bazick et al suggested that RDW was a strong predictive factor in critical patients (27). Also there are studies about association between thrombocytopenia (28, 32), MPV (33, 34) and mortality of ICU patients. In our study there were no significant differences regarding uric acid, triglyceride, total cholesterol, RDW, WBC, CRP and urea; whereas MPV, lymphocyte, neutrophile, NLR (neutrophile/lymphocyte ratio), PLT and creatinine levels were significantly different between deceased and surviving COPD patients ( 
